Insider Selling: Afya (NASDAQ:AFYA) CFO Sells $152,000.00 in Stock

Afya Limited (NASDAQ:AFYA) CFO Luis Andre Carpintero Blanco sold 10,000 shares of Afya stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $15.20, for a total value of $152,000.00. Following the sale, the chief financial officer directly owned 51,103 shares in the company, valued at approximately $776,765.60. This trade represents a 16.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Afya Stock Performance

AFYA opened at $15.07 on Monday. The business’s 50 day moving average is $14.48 and its 200-day moving average is $14.67. The stock has a market cap of $1.41 billion, a PE ratio of 10.32, a price-to-earnings-growth ratio of 0.67 and a beta of 0.48. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.41. Afya Limited has a twelve month low of $13.00 and a twelve month high of $19.90.

Afya (NASDAQ:AFYA) last released its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.05. The company had revenue of $147.08 million for the quarter, compared to analysts’ expectations of $174.74 million. Afya had a return on equity of 18.77% and a net margin of 20.31%. On average, analysts predict that Afya Limited will post 1.52 earnings per share for the current year.

Afya Dividend Announcement

The company also recently announced an annual dividend, which was paid on Monday, April 6th. Investors of record on Wednesday, March 25th were issued a dividend of $0.656 per share. The ex-dividend date of this dividend was Wednesday, March 25th. This represents a yield of 433.0%. Afya’s payout ratio is presently 45.21%.

Trending Headlines about Afya

Here are the key news stories impacting Afya this week:

• Positive Sentiment: Short interest fell materially in March — short interest declined about 14.1% to 541,994 shares as of March 31, leaving only ~0.6% of float shorted and a days-to-cover of ~4.4. Lower short interest reduces short pressure and can support upside or limit downside volatility.
• Positive Sentiment: Zacks upgraded Afya from “hold” to “strong-buy”, giving institutional and retail investors a fresh buy-side signal that can attract flows. Zacks upgrade
• Positive Sentiment: The company paid an annual dividend on April 6 ($0.656 per share). The payout returns cash to shareholders and can support investor demand, particularly for income-oriented holders. MarketBeat dividend/coverage
• Neutral Sentiment: Institutional activity: several funds established or increased positions in Q4 (State Street, XTX Topco, Mangrove Partners, etc.). High institutional ownership (~88%) can stabilize stock but also concentrate flows. MarketBeat institutional holdings
• Negative Sentiment: Large insider sale by VP Lelio De Souza Junior — sold 26,753 shares (~$400k) on April 7, reducing his stake by ~62%. Large insider reductions can be perceived negatively by investors and may weigh on near-term sentiment. SEC filing – De Souza Jr sale
• Negative Sentiment: Smaller insider sale by VP De Sousa Anibal Jose Grifo — sold 5,000 shares (~$76k) on April 7 (10% reduction in his position). While smaller than the other sale, it adds to insider-decrease headlines. InsiderTrades – De Sousa sale

Analyst Ratings Changes

AFYA has been the topic of several recent analyst reports. JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 target price (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. Sanford C. Bernstein raised Afya to a “market perform” rating in a report on Friday, January 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a report on Wednesday, January 21st. Wall Street Zen raised Afya from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 14th. Finally, Zacks Research raised Afya from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 7th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, Afya has a consensus rating of “Hold” and a consensus price target of $17.30.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Doma Perpetual Capital Management LLC grew its position in Afya by 50.6% in the third quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock worth $13,910,000 after buying an additional 299,419 shares during the last quarter. Swedbank AB grew its position in Afya by 170.3% in the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock worth $2,916,000 after buying an additional 119,200 shares during the last quarter. SPX Gestao de Recursos Ltda acquired a new position in Afya in the third quarter worth approximately $2,895,000. State Street Corp grew its position in Afya by 25.8% in the fourth quarter. State Street Corp now owns 126,914 shares of the company’s stock worth $1,955,000 after buying an additional 26,005 shares during the last quarter. Finally, GSA Capital Partners LLP grew its position in Afya by 45.5% in the third quarter. GSA Capital Partners LLP now owns 89,747 shares of the company’s stock worth $1,400,000 after buying an additional 28,053 shares during the last quarter. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.